Gestational trophoblastic neoplasia, version 2.2019

Nadeem R. Abu-Rustum, Catheryn M. Yashar, Sarah Bean, Kristin Bradley, Susana M. Campos, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Ernest Han, Warner K. Huh, John R. Lurain, Andrea Mariani, David MutchChrista Nagel, Larissa Nekhlyudov, Amanda NicklesFader, Steven W. Remmenga, R. R. KevinReynolds, Rachel Sisodia, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Nicole R. McMillian, Jillian Scavone

Research output: Contribution to journalReview articlepeer-review

81 Scopus citations


Gestational trophoblastic neoplasia (GTN), a subset of gestational trophoblastic disease (GTD), occurs when tumors develop in the cells that would normally form the placenta during pregnancy. The NCCN Guidelines for Gestational Trophoblastic Neoplasia provides treatment recommendations for various types of GTD including hydatidiform mole, persistent post-molar GTN, low-risk GTN, highrisk GTN, and intermediate trophoblastic tumor.

Original languageEnglish
Pages (from-to)1374-1391
Number of pages18
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number11
StatePublished - 2019


Dive into the research topics of 'Gestational trophoblastic neoplasia, version 2.2019'. Together they form a unique fingerprint.

Cite this